Related Experiment Video
Updated: Mar 22, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Diabetes Care in Venezuela
Ramfis Nieto-Martínez1, Juan P González-Rivas2, Marcos Lima-Martínez3
1Department of Physiology, School of Medicine, Universidad Centro-Occidental "Lisandro Alvarado" and Cardio-metabolic Unit 7, Barquisimeto, Venezuela; Department of Physiology, School of Medicine, University of Panamá, Panama City, Panamá.
Type 2 diabetes (T2D) is a growing concern in Venezuela, with a 7.7% prevalence and significant mortality. Improving T2D management requires enhanced resources, education, and integrated health policies.
Area of Science:
- Endocrinology and Metabolic Diseases
- Public Health and Epidemiology
- Health Policy and Management
Background:
- Rising incidence and economic burden of type 2 diabetes (T2D) in Venezuela present significant public health challenges.
- The country's socio-economic turmoil exacerbates difficulties in managing the escalating T2D epidemic.
Purpose of the Study:
- To conduct a comprehensive review of diabetes mellitus and its complications in Venezuela.
- To analyze the prevalence, etiological factors, prevention strategies, management approaches, health policies, and associated challenges.
Main Methods:
- A literature review from 1960 to 2015, including non-indexed literature.
- Estimation of weighted prevalence for diabetes and prediabetes using population-based studies.
- Analysis of existing diabetes care strategies and health system's approach.
Main Results:
- Weighted prevalence of diabetes at 7.7% and prediabetes at 11.2% in Venezuela.
- Diabetes as the fifth leading cause of death (7.1% in 2012), with a 7% annual mortality increase (1990-2012).
- Cardiovascular disease and diabetes combined were the leading cause of disability-adjusted life years in 2012; T2D drivers include genetics, lifestyle, obesity, and insulin resistance, with suboptimal screening and fragmented care.
Conclusions:
- Recommended strategies include resource enhancement, cost reduction, improved education, and implementing screening tools like the Latin America Finnish Diabetes Risk Score.
- Promoting dedicated diabetes care units and optimizing diagnostic and treatment guidelines (e.g., metformin as first-line therapy) are crucial.
- Reducing health system fragmentation and utilizing adapted algorithms for lifestyle and pharmacologic interventions can aid primary care physicians.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

